Last reviewed · How we verify
The Utility of Insulin Glargine (Lantus) Compared to NPH in Ethnic Minority Type 2 Diabetic Subjects Starting Insulin Therapy
To compare the efficacy and safety of once-nightly insulin glargine versus a single morning injection of glargine or once-nightly NPH insulin in ethnic minority type 2 diabetic patients inadequately controlled on combination oral agents.
Details
| Lead sponsor | Charles Drew University of Medicine and Science |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 108 |
| Start date | 2003-02 |
| Completion | 2009-08 |
Conditions
- Type 2 Diabetes Mellitus
Interventions
- 1- Insulin glargine QHS
- 2 - Insulin glargine QAM
- 3 - NPH insulin QHS
Primary outcomes
- Hemoglobin A1c Change From Baseline — Baseline to 6 months
Countries
United States